Sunaina Indermun

Sunaina Indermun

Auto-generated profile, based on publicly available information

Sunaina Indermun

Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, 7 York Road, Parktown, 2193, South Africa

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Carbohydrate Polymers
Verified
Journal Article
Closed access
NMNonhlanhla Masina
Nonhlanhla Masina
Yahya ChoonaraYahya Choonara
Yahya Choonara
PKPradeep Kumar
Pradeep Kumar
LTLisa du Toit
Lisa du Toit
Mershen GovenderMershen Govender
Mershen Govender
VPViness Pillay
Viness Pillay

1 July 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
SISunaina Indermun
Sunaina Indermun
RLRegina Luttge
Regina Luttge
Yahya ChoonaraYahya Choonara
Yahya Choonara
PKPradeep Kumar
Pradeep Kumar
LTLisa du Toit
Lisa du Toit
VPViness Pillay
Viness Pillay

1 February 2014 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SISunaina Indermun
Sunaina Indermun
Yahya ChoonaraYahya Choonara
Yahya Choonara
PKPradeep Kumar
Pradeep Kumar
LTLisa du Toit
Lisa du Toit
GMGirish Modi
Girish Modi
VPViness Pillay
Viness Pillay

1 December 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SISunaina Indermun
Sunaina Indermun
Yahya ChoonaraYahya Choonara
Yahya Choonara
PKPradeep Kumar
Pradeep Kumar
LTLisa du Toit
Lisa du Toit
GMGirish Modi
Girish Modi
VPViness Pillay
Viness Pillay

17 May 2018 in Viruses
Verified
Journal Article
Open access
PDF file
LSLatavia Singh
Latavia Singh
SISunaina Indermun
Sunaina Indermun
Mershen GovenderMershen Govender
Mershen Govender
PKPradeep Kumar
Pradeep Kumar
LTLisa du Toit
Lisa du Toit
VPViness Pillay
Viness Pillay
Chronic hepatitis B virus (HBV) infection poses a significant health challenge due to associated morbidity and mortality from cirrhosis and hepatocellular cancer that eventually results in the breakdown of liver functionality. Nanotechnology has the potential to play a pivotal role in reducing viral load levels and drug-resistant HBV through drug targeting, thus reducing the rate of evolution of the disease. Apart from tissue targeting, intracellular delivery of a wide range of drugs is necessary to exert a therapeutic action in the affected organelles. This review encompasses the strategies and techniques that have been utilized to target the HBV-infected nuclei in liver hepatocytes, with a significant look at the new insights and most recent advances in drug carriers and their role in anti-HBV therapy.

13 June 2018 in Materials
Verified
Journal Article
Open access
PDF file
Mershen GovenderMershen Govender
Mershen Govender
SISunaina Indermun
Sunaina Indermun
PKPradeep Kumar
Pradeep Kumar
Yahya ChoonaraYahya Choonara
Yahya Choonara
VPViness Pillay
Viness Pillay
3D printed polycaprolactone (PCL)-blended scaffolds have been designed, prepared, and evaluated in vitro in this study prior to the incorporation of a polyvinyl alcohol–polyacrylic acid (PVA–PAA) hydrogel for the delivery of in situ-formed sodium indomethacin. The prepared PCL–PVA–PAA scaffold is proposed as a potential structural support system for load-bearing tissue damage where inflammation is prevalent. Uniaxial strain testing of the PCL-blended scaffolds were undertaken to determine the scaffold’s resistance to strain in addition to its thermal, structural, and porosimetric properties. The viscoelastic properties of the incorporated PVA–PAA hydrogel has also been determined, as well as the drug release profile of the PCL–PVA–PAA scaffold. Results of these analyses noted the structural strength, thermal stability, and porosimetric properties of the scaffold, as well as the ability of the PCL–PVA–PAA scaffold to deliver sodium indomethacin in simulated physiological conditions of pH and temperature. The results of this study therefore highlight the successful design, fabrication, and in vitro evaluation of a 3D printed polymeric strain-resistant supportive platform for the delivery of sodium indomethacin.